ENDOGENOUS REGULATORS OF DRUG METABOLISM

药物代谢的内源性调节因子

基本信息

  • 批准号:
    2022456
  • 负责人:
  • 金额:
    $ 27.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1992
  • 资助国家:
    美国
  • 起止时间:
    1992-02-01 至 2001-07-31
  • 项目状态:
    已结题

项目摘要

The broad objective of this proposal is to investigate the mechanism(s) by which growth hormone (GH) regulates the sexually dimorphic expression of hepatic isoforms of cytochrome P450 (P450; CYP), which impacts on recently raised concerns regarding the gender- effectiveness of therapeutic agents. Having identified the fundamental elements in the sexually dimorphic plasma GH profiles that "signal" the transcription and/or translation of the primary rat constitutive sex- dependent P450s, we now propose to examine the mechanism(s) by which the hepatocyte recognizes and discriminates between the sexually dimorphic signals in the GH profiles and transduces their messages to the nucleus. We hypothesize that the different extracellular signals in the circulating GH profiles differentially regulate binding kinetics and/or translocation of the GH receptor (GHR) which in turn activates specific signal transduction pathways responsible for initiation the transcription of selective gender- dependent isoforms of P450. Since male-specific CYP2C11 and female-specific (CYP2C12 are the primary rat isoforms representing up to 50% of the total hepatic P450 content in their respective sexes, and we have already identified the fundamental GH signals required for their selective expression, we have chosen these isoforms as prototypes in the following studies. We plan to specifically restor hepatic CYP2C12 expression in GH-depleted female rats and CYP2C11 expression in GH-depleted male rats by infusing them with what we have determined to be the selectively effective gender- dependent GH profiles in order to identify the signaling molecules involved in their regulation. Expression levels of hepatic P450s are gender-dependent in the adult rat and regardless of the treatment, males can not be induced to express the full female pattern of hepatic P450s nor can females be treated to express the normal male pattern. We hypothesize that this adult hormone-independent and -irreversible response in imprinted by perinatal (e.g. androgens or estrogens) or peripubertal (e.g. sex steroids or GH) hormones that result in a reduced responsiveness of signal transduction pathways in one sex to the gender-dependent plasma GH profiles of the opposite sex. To test this hypothesis we plan to examine P450-dependent signal transduction pathways in rats infused with the opposite gender-specific plasma GH profiles. Lastly, we plan to test our hypothesis that perinatal and/or peripubertal hormones imprint the irreversible, sex-dependent responsiveness of CYP2C11 and 2C12 to GH regulation by administering or selectively ablating the presumptive hormones during the imprinting period and evaluating the plasticity of the isoforms to GH-induced sex reversal in adulthood.
本提案的总体目标是调查机制 生长激素(GH)通过其调节性二态性 细胞色素P450(P450; P450)的肝同种型的表达, 这影响到最近提出的关于性别问题的关切- 治疗剂的有效性。 在确定了基本的 性二态血浆GH谱中的“信号”元素 原代大鼠组成性性别的转录和/或翻译- 依赖性P450,我们现在建议通过以下方式检查机制: 肝细胞识别并区分 性二态信号在生长激素档案和转导他们的 向细胞核发送信息。 我们假设, 循环GH谱中的细胞外信号差异 调节GH受体的结合动力学和/或易位 (GHR)进而激活特定的信号传导途径 负责启动选择性性别的转录- P450的依赖性亚型。 由于男性特异性CYP 2C 11和 雌性特异性(CYP 2C 12是主要的大鼠同种型, 在其各自性别中高达肝脏P450总含量的50%, 我们已经确定了所需的基本GH信号 对于它们的选择性表达,我们选择这些异构体作为 以下研究中的原型。 我们计划专门恢复 GH耗竭雌性大鼠肝脏CYP 2C 12表达, 通过向GH耗竭的雄性大鼠输注CYP 2C 11表达 我们已经确定了选择性有效的性别- 依赖GH谱,以鉴定信号分子 参与其监管。 成人肝脏P450表达水平具有性别依赖性 大鼠和无论处理,雄性不能诱导 表达肝脏P450的完全女性模式, 被用来表现正常的男性特征 我们假设这 成年人的非依赖性和不可逆的反应,在印迹 围产期(如雄激素或雌激素)或青春期(如性别 类固醇或生长激素)激素,其导致 信号转导途径在一个性别的性别依赖 异性的血浆GH谱。 为了验证这一假设, 计划在大鼠中检测P450依赖的信号转导通路 输注相反性别特异性血浆GH曲线。 最后, 我们计划验证我们的假设,即围产期和/或青春期 激素会使人产生不可逆的、依赖于性别的反应, CYP 2C 11和2C 12通过给药或选择性给药对GH的调节 在印记期间消除假定的激素, 评估同种型对GH诱导的性逆转的可塑性, 成年

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BERNARD Harris SHAPIRO其他文献

BERNARD Harris SHAPIRO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BERNARD Harris SHAPIRO', 18)}}的其他基金

Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
激素印记预先决定细胞色素 P450 的发育表达
  • 批准号:
    8686904
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
激素印记预先决定细胞色素 P450 的发育表达
  • 批准号:
    8469068
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
激素印记预先决定细胞色素 P450 的发育表达
  • 批准号:
    7872047
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
激素印记预先决定细胞色素 P450 的发育表达
  • 批准号:
    8089388
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
激素印记预先决定细胞色素 P450 的发育表达
  • 批准号:
    8301001
  • 财政年份:
    2010
  • 资助金额:
    $ 27.83万
  • 项目类别:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
药物代谢的内源性调节因子
  • 批准号:
    3305188
  • 财政年份:
    1992
  • 资助金额:
    $ 27.83万
  • 项目类别:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
药物代谢的内源性调节因子
  • 批准号:
    3305189
  • 财政年份:
    1992
  • 资助金额:
    $ 27.83万
  • 项目类别:
Endogenous Regulators of Drug Metabolism
药物代谢的内源性调节剂
  • 批准号:
    6469991
  • 财政年份:
    1992
  • 资助金额:
    $ 27.83万
  • 项目类别:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
药物代谢的内源性调节因子
  • 批准号:
    2183380
  • 财政年份:
    1992
  • 资助金额:
    $ 27.83万
  • 项目类别:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
药物代谢的内源性调节因子
  • 批准号:
    2749881
  • 财政年份:
    1992
  • 资助金额:
    $ 27.83万
  • 项目类别:

相似海外基金

Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
  • 批准号:
    10930196
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
Nonalcoholic Fatty Liver Disease (NAFLD) in Polycystic Ovary Syndrome: The Role of Androgens on Liver Injury and NAFLD Progression
多囊卵巢综合征中的非酒精性脂肪肝 (NAFLD):雄激素在肝损伤和 NAFLD 进展中的作用
  • 批准号:
    10735807
  • 财政年份:
    2023
  • 资助金额:
    $ 27.83万
  • 项目类别:
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
  • 批准号:
    10418461
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
Sexual Differentiation of the Brain and Behaviour: Central and Peripheral Targets of Androgens
大脑和行为的性别分化:雄激素的中枢和外周目标
  • 批准号:
    RGPIN-2019-04999
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Discovery Grants Program - Individual
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10570208
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10688086
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD
雄激素对患有 NAFLD 的年轻女性组织特异性脂质代谢和肝损伤的影响
  • 批准号:
    10355174
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome
使用新型 11-含氧雄激素提高多囊卵巢综合征的诊断准确性和治疗效果
  • 批准号:
    10431620
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
Defining the impact of androgens on uterine immune cell function during endometrial tissue repair
确定子宫内膜组织修复过程中雄激素对子宫免疫细胞功能的影响
  • 批准号:
    2744296
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
    Studentship
Paxillin and Androgens in the Regulation of Ovarian Follicle Development
桩蛋白和雄激素在卵巢卵泡发育调节中的作用
  • 批准号:
    10525097
  • 财政年份:
    2022
  • 资助金额:
    $ 27.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了